Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Compugen Ltd (CGEN)

Compugen Ltd (CGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 152,600
  • Shares Outstanding, K 89,240
  • Annual Sales, $ 27,860 K
  • Annual Income, $ -14,230 K
  • EBIT $ -32 M
  • EBITDA $ -33 M
  • 60-Month Beta 2.86
  • Price/Sales 22.85
  • Price/Cash Flow N/A
  • Price/Book 3.40

Options Overview Details

View History
  • Implied Volatility 144.84% (-73.44%)
  • Historical Volatility 83.21%
  • IV Percentile 27%
  • IV Rank 21.80%
  • IV High 664.40% on 09/19/25
  • IV Low 0.01% on 09/08/25
  • Expected Move (DTE 10) 0.8160 (45.71%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 42
  • Volume Avg (30-Day) 68
  • Put/Call OI Ratio 0.09
  • Today's Open Interest 3,503
  • Open Int (30-Day) 3,338
  • Expected Range 0.9690 to 2.6010

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 5
  • High Estimate 0.56
  • Low Estimate -0.08
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +171.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5800 +12.97%
on 02/05/26
2.3800 -25.00%
on 01/16/26
-0.0950 (-5.05%)
since 01/09/26
3-Month
1.4300 +24.83%
on 12/30/25
2.3800 -25.00%
on 01/16/26
+0.1150 (+6.89%)
since 11/10/25
52-Week
1.1300 +57.96%
on 04/09/25
2.4100 -25.93%
on 02/11/25
-0.6350 (-26.24%)
since 02/10/25

Most Recent Stories

More News
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

HOLON, Israel , Dec. 17, 2025 /PRNewswire/ --  Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.7700 (+3.51%)
Compugen: Q3 Earnings Snapshot

Compugen: Q3 Earnings Snapshot

CGEN : 1.7700 (+3.51%)
Compugen Reports Third Quarter 2025 Results

HOLON, Israel , Nov. 10, 2025 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.7700 (+3.51%)
Compugen to Participate in Stifel 2025 Healthcare Conference

HOLON, Israel , Nov. 4, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 1.7700 (+3.51%)
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

HOLON, Israel , Oct. 27, 2025 /PRNewswire/ --  Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational drug target...

CGEN : 1.7700 (+3.51%)
Analysts Offer Insights on Healthcare Companies: Compugen (CGEN) and AbbVie (ABBV)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Compugen (CGEN – Research Report) and AbbVie (ABBV – Research Report) with bullish sentiments.Elevate...

CGEN : 1.7700 (+3.51%)
ABBV : 222.40 (-0.39%)
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025

HOLON, Israel , Oct. 13, 2025 /PRNewswire/ --  Compugen Ltd.  (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery...

CGEN : 1.7700 (+3.51%)
Compugen to Present at SITC 2025

HOLON, Israel , Oct. 6, 2025 /PRNewswire/ -- Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational target discovery,...

CGEN : 1.7700 (+3.51%)
Compugen to Present Research at the Single Cell Genomics 2025 Conference

HOLON, ISRAEL , Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in predictive computational...

CGEN : 1.7700 (+3.51%)
Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HOLON, Israel , Aug. 28, 2025 /PRNewswire/ --  Compugen Ltd.  (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive computational...

CGEN : 1.7700 (+3.51%)

Business Summary

Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas...

See More

Key Turning Points

3rd Resistance Point 1.8000
2nd Resistance Point 1.7600
1st Resistance Point 1.7350
Last Price 1.7700
1st Support Level 1.6700
2nd Support Level 1.6300
3rd Support Level 1.6050

See More

52-Week High 2.4100
Fibonacci 61.8% 1.9210
Fibonacci 50% 1.7700
Last Price 1.7700
Fibonacci 38.2% 1.6190
52-Week Low 1.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar